Indaptus Therapeutics Stock Forecast

Sell candidate since Jul 08, 2026 Gain 7.35%

No changes to the price of Indaptus Therapeutics, Inc. stock on the last trading day (Monday, 13th Jul 2026). During the last trading day the stock fluctuated 4.78% from a day low at $2.51 to a day high of $2.63. The price has fallen in 6 of the last 10 days and is down by -22.87% for this period.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 12.17% during the next 3 months and, with a 90% probability hold a price between $1.53 and $5.58 at the end of this 3-month period.

INDP Signals & Forecast

There are few to no technical positive signals at the moment. The Indaptus Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.68 and $2.79. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -44.63%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point".

Support, Risk & Stop-loss for Indaptus Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.45 and $2.10. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Indaptus Therapeutics, Inc. finds support just below today's level at $2.45. If this is broken, then the next support from accumulated volume will be at $2.10 and $2.03.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.120 between high and low, or 4.78%. For the last week the stock has had daily average volatility of 6.98%.

Indaptus Therapeutics, Inc. is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INDP) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Indaptus Therapeutics, Inc. to open at $2.59, and during the day (based on 14 day Average True Range), to move between $2.40 and $2.86, which gives a possible trading interval of +/-$0.464 (+/-19.34%) up or down from last closing price. If Indaptus Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 19.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.45 (6.84%) than the resistance at $3.00 (14.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Indaptus Therapeutics, Inc. stock A Buy?

The Indaptus Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Indaptus Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.125 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $2.59 ( 1.52%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk